Trial Profile
Comparison of 3 different formulations of clopidogrel versus prasugrel in patients with coronary artery disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Mar 2013
Price :
$35
*
At a glance
- Drugs Clopidogrel (Primary) ; Prasugrel
- Indications Coronary artery disease; Embolism and thrombosis
- Focus Pharmacodynamics
- Acronyms CLO-CLO
- 21 Mar 2013 New trial record